Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.

Ohno H, Ueda C, Akasaka T.

Leuk Lymphoma. 2000 Feb;36(5-6):435-45. Review.

PMID:
10784387
2.

Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.

Hamada T, Yonetani N, Ueda C, Maesako Y, Akasaka H, Akasaka T, Ohno H, Kawakami K, Amakawa R, Okuma M.

Br J Haematol. 1998 Aug;102(3):691-700.

PMID:
9722295
3.

Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma.

Morrison AM, Jäger U, Chott A, Schebesta M, Haas OA, Busslinger M.

Blood. 1998 Nov 15;92(10):3865-78.

4.

The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene.

Iida S, Rao PH, Nallasivam P, Hibshoosh H, Butler M, Louie DC, Dyomin V, Ohno H, Chaganti RS, Dalla-Favera R.

Blood. 1996 Dec 1;88(11):4110-7.

5.

Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32).

Iida S, Rao PH, Ueda R, Chaganti RS, Dalla-Favera R.

Leuk Lymphoma. 1999 Jun;34(1-2):25-33. Review.

PMID:
10350329
6.

Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.

Souabni A, Jochum W, Busslinger M.

Blood. 2007 Jan 1;109(1):281-9. Epub 2006 Sep 12.

7.

The paired box domain gene PAX5 is fused to ETV6/TEL in an acute lymphoblastic leukemia case.

Cazzaniga G, Daniotti M, Tosi S, Giudici G, Aloisi A, Pogliani E, Kearney L, Biondi A.

Cancer Res. 2001 Jun 15;61(12):4666-70.

8.
9.

t(9;14)(p13;q32) involving the PAX-5 gene: a unique subtype of 14q32 translocation in B cell non-Hodgkin's lymphoma.

Amakawa R, Ohno H, Fukuhara S.

Int J Hematol. 1999 Feb;69(2):65-9. Review.

PMID:
10071452
10.

Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma.

Busslinger M, Klix N, Pfeffer P, Graninger PG, Kozmik Z.

Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6129-34.

11.

Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements.

George TI, Wrede JE, Bangs CD, Cherry AM, Warnke RA, Arber DA.

J Mol Diagn. 2005 Aug;7(3):346-51.

12.

Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.

Krenacs L, Himmelmann AW, Quintanilla-Martinez L, Fest T, Riva A, Wellmann A, Bagdi E, Kehrl JH, Jaffe ES, Raffeld M.

Blood. 1998 Aug 15;92(4):1308-16.

13.

PAX5/IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements.

Poppe B, De Paepe P, Michaux L, Dastugue N, Bastard C, Herens C, Moreau E, Cavazzini F, Yigit N, Van Limbergen H, De Paepe A, Praet M, De Wolf-Peeters C, Wlodarska I, Speleman F.

Genes Chromosomes Cancer. 2005 Oct;44(2):218-23.

PMID:
15942942
14.

PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).

Sato K, Sakai H, Kato M, Nishio Y, Tsuruoka Y, Uemura Y, Yokoi S, Saito T, Matsunawa M, Suzuki Y, Isobe Y, Inoue Y, Takahashi M, Miura I.

Int J Hematol. 2015 Jun;101(6):608-11. doi: 10.1007/s12185-015-1749-5. Epub 2015 Jan 30.

PMID:
25633778
15.

t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation.

Offit K, Parsa NZ, Filippa D, Jhanwar SC, Chaganti RS.

Blood. 1992 Nov 15;80(10):2594-9.

16.

Lack of somatic hypermutation of IG V(H) genes in lymphoid malignancies with t(2;14)(p13;q32) translocation involving the BCL11A gene.

Küppers R, Sonoki T, Satterwhite E, Gesk S, Harder L, Oscier DG, Tucker PW, Dyer MJ, Siebert R.

Leukemia. 2002 May;16(5):937-9.

17.

Non-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1.

Rouhigharabaei L, Finalet Ferreiro J, Tousseyn T, van der Krogt JA, Put N, Haralambieva E, Graux C, Maes B, Vicente C, Vandenberghe P, Cools J, Wlodarska I.

PLoS One. 2014 Jan 9;9(1):e85851. doi: 10.1371/journal.pone.0085851. eCollection 2014.

18.

Three new cases of non-Hodgkin lymphoma with t(9;14)(p13;q32).

Andrieux J, Fert-Ferrer S, Copin MC, Huyghe P, Pocachard P, Lespinasse J, Bauters F, Laï JL, Quesnel B.

Cancer Genet Cytogenet. 2003 Aug;145(1):65-9.

PMID:
12885465
19.

Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation.

Morrison AM, Nutt SL, Thévenin C, Rolink A, Busslinger M.

Semin Immunol. 1998 Apr;10(2):133-42. Review.

PMID:
9618759
20.

Detection of chimaeric transcripts of the immunoglobulin heavy chain and BCL6 genes by reverse-transcriptase polymerase chain reaction in B-cell non-Hodgkin's lymphomas.

Kawamata N, Nakamura Y, Miki T, Sato E, Isobe Y, Furusawa S, Hirosawa S, Oshimi K.

Br J Haematol. 1998 Mar;100(3):484-9.

PMID:
9504630

Supplemental Content

Support Center